Subscribe
Business

Merck Q4 net profit more than doubles

By David McHugh
Published
Add Washington Examiner on Google

FRANKFURT, Germany (AP) — Merck KGaA saw its profit more than double in the fourth quarter as the German pharmaceutical company benefited from higher prices for its Rebif multiple sclerosis drug and reaped rewards from its ongoing restructuring.

The Darmstadt-based company said Thursday that its net profit rose to €272 million ($355 million), from €133 million in the same quarter the year before. Revenues rose 8 percent to €2.83 billion.

Print subscriber? Click here to login/register your account
Digital subscriber? Click here to login/register your account.

Full midterm coverage.Deeper analysis.

Get unlimited access to Washington Examiner's reporting, expert analysis, and coverage of the midterm elections.

Get Unlimited Access

Cancel anytime.